Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:56:51.928Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:56:51.928Z.
Quote observation: 2026-10-06T15:54:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5f3696a2d024229c19dd1691f2f438020e28c75ff27c8cf4c9d796e14bd4a3b5
FORWARD PE RATIO
N/A
iTonic Holdings Ltd.
Market Cap
$26.08M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| iTonic Holdings Ltd. (ITOC) | $26.08M | N/A |
| InspireMD, Inc. (NSPR)vs › | $26.58M | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.21M | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.70M | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.54M | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $23.96M | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.64M | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $22.87M | N/A |
| OneMedNet Corporation (ONMD)vs › | $29.44M | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.65M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
